Expression and Clinical Significance of Paxillin and HER-2 in Breast Carcinoma

SUN Xinghua,WANG Yahong,MA Bin,LI Hui,GAO Zhian
DOI: https://doi.org/10.3969/j.issn.1674-0424.2009.03.005
2009-01-01
Abstract:Objective To explore the clinical significance of Paxillin and HER-2 expression in the breast carcinoma.MethodsThe expression of Paxillin and HER-2 were detected by immunohistochemistry(IHC) in 80 cases of breast carcinoma,of which 15 cases of breast had benign lesions and 10 cases were normal breasts with normal tissues.Results(1)The positive rates of paxillin protein were 30.0%,33.3% and 71.3% in normal breast tissues,breast benign lesion and breast carcinoma respectively.HER-2 protein were 0%,0% and 33.8% respectively.(2)The expression of paxillin was related to pathological stages and lymph node metastasis,but not to histological type and histological grades.While the expression of HER-2 was related to ER status,histological grades and lymph node metastasis,but not to histological type and pathological stages.(3)There was positive correlation between paxillin and HER-2 levels.ConclusionsThe test of paxillin and HER-2 proteins expression may have significant prognostic value for assessing the degree of malignancy and potential lymph node metastasis probability in breast carcinoma.
What problem does this paper attempt to address?